Seth P. Lerner

Research interests

Publications

• Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors

  European Urology · 2023 · https://doi.org/10.1016/j.eururo.2023.03.029

• Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

  The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30540-4

• Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling

  Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-10873-y

• Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)

  European Urology · 2018 · https://doi.org/10.1016/j.eururo.2018.04.029

• Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

  Cell · 2018 · https://doi.org/10.1016/j.cell.2018.07.036

• Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset

  European Urology · 2017 · https://doi.org/10.1016/j.eururo.2017.03.010

• Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

  European Urology · 2017 · https://doi.org/10.1016/j.eururo.2017.03.030

• Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

  The Journal of Urology · 2017 · https://doi.org/10.1016/j.juro.2017.04.086

• Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)

  World Journal of Urology · 2016 · https://doi.org/10.1007/s00345-016-1928-x

• Bladder cancer

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)30512-8

• Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature

  European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.01.032

• Genome-wide association study identifies multiple loci associated with bladder cancer risk

  Human Molecular Genetics · 2013 · https://doi.org/10.1093/hmg/ddt519

• Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes

  British Journal of Urology · 2013 · https://doi.org/10.1111/bju.12121

• ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder

  European Urology · 2012 · https://doi.org/10.1016/j.eururo.2012.08.009

• International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy

  British Journal of Urology · 2010 · https://doi.org/10.1111/j.1464-410x.2010.09217.x

• Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients

  The Journal of Urology · 2010 · https://doi.org/10.1016/j.juro.2010.02.021

• Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort

  European Urology · 2009 · https://doi.org/10.1016/j.eururo.2009.09.024

• A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study

  The Journal of Urology · 2007 · https://doi.org/10.1016/j.juro.2007.03.028

• Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium

  The Journal of Urology · 2006 · https://doi.org/10.1016/j.juro.2006.08.004

• Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.05.516

Current projects

No projects listed.